These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 33471794

  • 1. Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
    Liu Q, Yang D, Qiu B, Martinez L, Ji Y, Song H, Li Z, Wang J.
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009068. PubMed ID: 33471794
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
    Li Q, Wang Y, Li Y, Gao H, Zhang Z, Feng F, Dai E.
    J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465
    [Abstract] [Full Text] [Related]

  • 3. Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.
    Bablishvili N, Tukvadze N, Shashkina E, Mathema B, Gandhi NR, Blumberg HM, Kempker RR.
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
    [Abstract] [Full Text] [Related]

  • 4. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J, Sovkhozova N, Vinnikov D, Goncharova Z, Talaibekova E, Aldasheva N, Aldashev A.
    BMC Microbiol; 2018 Mar 22; 18(1):22. PubMed ID: 29566660
    [Abstract] [Full Text] [Related]

  • 5. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
    Ko DH, Lee EJ, Lee SK, Kim HS, Shin SY, Hyun J, Kim JS, Song W, Kim HS.
    Ann Clin Microbiol Antimicrob; 2019 Jan 03; 18(1):2. PubMed ID: 30606210
    [Abstract] [Full Text] [Related]

  • 6. Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand.
    Suthum K, Samosornsuk W, Samosornsuk S.
    J Infect Dev Ctries; 2020 Mar 31; 14(3):268-276. PubMed ID: 32235087
    [Abstract] [Full Text] [Related]

  • 7. Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.
    Rahman A, Ferdous SS, Ahmed S, Rahman SMM, Uddin MKM, Pholwat S, Gratz J, Houpt E, Banu S.
    Antimicrob Agents Chemother; 2017 Sep 31; 61(9):. PubMed ID: 28630193
    [Abstract] [Full Text] [Related]

  • 8. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
    Xia H, van den Hof S, Cobelens F, Zhou Y, Zhao B, Wang S, Zhao Y.
    BMC Infect Dis; 2020 Jan 07; 20(1):19. PubMed ID: 31910878
    [Abstract] [Full Text] [Related]

  • 9. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM, Ahmad S, Mokaddas EM.
    Eur J Med Res; 2019 Dec 05; 24(1):38. PubMed ID: 31806020
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y, Zhu D, Zheng H, Shen J, Hu Y, Liu J, Zhao Y.
    BMC Infect Dis; 2017 Nov 06; 17(1):711. PubMed ID: 29110640
    [Abstract] [Full Text] [Related]

  • 11. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN, Hwang SC, Park YK, Kim H, Lee YS, Chung GT, Choe KH, Ryoo S.
    Diagn Microbiol Infect Dis; 2013 Jun 06; 76(2):187-96. PubMed ID: 23561273
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.
    Luo D, Chen Q, Xiong G, Peng Y, Liu T, Chen X, Zeng L, Chen K.
    Sci Rep; 2019 May 13; 9(1):7315. PubMed ID: 31086215
    [Abstract] [Full Text] [Related]

  • 13. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
    Simons SO, van der Laan T, Mulder A, van Ingen J, Rigouts L, Dekhuijzen PN, Boeree MJ, van Soolingen D.
    Clin Microbiol Infect; 2014 Oct 13; 20(10):1015-20. PubMed ID: 24890253
    [Abstract] [Full Text] [Related]

  • 14. Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco.
    Momen G, Aainouss A, Lamaammal A, Chettioui F, Blaghen M, Messoudi M, Belghmi K, Mouslim J, El Mzibri M, El Messaoudi MD, Khyatti M, Chaoui I.
    Rev Inst Med Trop Sao Paulo; 2021 Oct 13; 63():e19. PubMed ID: 33787739
    [Abstract] [Full Text] [Related]

  • 15. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
    Zhang Z, Lu J, Liu M, Wang Y, Qu G, Li H, Wang J, Pang Y, Liu C, Zhao Y.
    J Infect; 2015 Apr 13; 70(4):335-45. PubMed ID: 25485999
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China.
    Liu Y, Sun Y, Zhang X, Zhang Z, Xing Q, Ren W, Yao C, Yu J, Ding B, Wang S, Li C.
    Epidemiol Infect; 2021 Jan 05; 149():e21. PubMed ID: 33397543
    [Abstract] [Full Text] [Related]

  • 17. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z, Napiórkowska A, Kamiński M, Augustynowicz-Kopeć E, Zwolska Z, Bielecki J, Jagielski T.
    J Microbiol Immunol Infect; 2016 Jun 05; 49(3):439-44. PubMed ID: 26117528
    [Abstract] [Full Text] [Related]

  • 18. Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India.
    Gupta A, Sinha P, Rathod S, Shanmugam SK, Uma Devi KR, Anupurba S, Nema V.
    Indian J Med Res; 2020 Apr 05; 151(4):361-370. PubMed ID: 32461400
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil.
    Salvato RS, Schiefelbein S, Barcellos RB, Praetzel BM, Anusca IS, Esteves LS, Halon ML, Unis G, Dias CF, Miranda SS, de Almeida IN, de Assis Figueredo LJ, Silva EC, Kritski AL, Dalla Costa ER, Rossetti MLR.
    Epidemiol Infect; 2019 Jan 05; 147():e216. PubMed ID: 31364547
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W, Chen J, Shen Y, Jin J, Wu J, Sun F, Wu Y, Xie L, Zhang Y, Zhang W.
    Clin Microbiol Infect; 2018 Sep 05; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.